Marine Biomedical Submits 510(k) Application to the U.S. FDA for PearlBone™.

This marks a significant regulatory milestone and reflects years of disciplined scientific development, regulatory preparation and manufacturing execution led by the team.

Marine Biomedical announces strategic investment and commercial arrangement with Orthocell

In an exhilarating culmination of breakthrough research, development, and dedication, Marine Biomedical is now at the forefront of the biomedical innovation sector.